In order to explore potential inhibitor of PCa and validate the value of FOXM1-NEIL3 regulatory axis as therapy target, we utilized CMap algorithm to uncover small molecular inhibitors of the axis. The gene discussed is NEIL3; the disease is posterior cortical atrophy.